| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
1 Department of Obstetrics and Gynecology, Erlangen University Hospital, D-91054 Erlangen, Germany and 2 Department of Obstetrics and Gynecology, Mainz University Hospital, Langenbeckstrasse 1, D-55124 Mainz, Germany
Correspondence should be addressed to T Maltaris; Email: maltaris{at}uni-mainz.de
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The most promising method for fertility preservation in these patients is the cryopreservation of ovarian tissue before oncological treatments, because of the large number of follicles that survive the freezing/thawing procedure (Donnez & Bassil 1998, Aubard et al. 2001, Liu et al. 2003). The problem that arises after the cryopreservation is how to use this frozen material in order to achieve a pregnancy. The majority of follicles that survive cryopreservation are primordial (Newton et al. 1996, Candy et al. 1997, Gook et al. 1999, Broecke Van den et al. 2001).
Two pregnancies have already been achieved after cryopreservation and retransplantation of ovarian tissue (Donnez et al. 2004, Meirow et al. 2005), and cryopreservation of ovarian tissue is being offered due to its future therapeutic potential by many groups.
Oktay et al.(1998) and Gook et al.(2001) observed a primordial follicle loss in xenotransplanted frozen/thawed human ovarian tissue after gonadotropin stimulation. A possible cause of the accelerated depletion of the primordial follicle pool could be a toxic effect of luteinizing hormone (LH) or follicle-stimulating hormone (FSH), as has already been suggested by Richardson et al. (Richardson & Nelson 1990). Flaws et al.(1997) showed that chronically elevated LH levels deplete the primordial follicle pool and thus may hasten the onset of reproductive senescence. Gonadotropin-releasing hormone (GnRH) analogs are able to prevent LH/FSH secretion of the pituitary gland in humans and rodents (Schally et al. 1980, Recabarren et al. 1991).
The aim of the study was to examine prospectively the effect of a gonadotropin-releasing hormone agonist (GnRH-a; triptorelin) on the number of follicles in different developmental stages of cryopreserved human ovarian grafts transplanted to gonadotropin-stimulated or not stimulated severe combined immunodeficient mice (SCID mice) and to test the hypothesis that GnRH agonist treatment may be able to prevent primordial follicular depletion.
| Material and Methods |
|---|
|
|
|---|
Patients
Seven patients between 10 and 34 (median 24) years of age were included in this study following informed consent and approval of the local university ethical committee. All patients suffered from malignant diseases (Table 1
) and wanted to cryopreserve ovarian tissue for a future pregnancy before the chemotherapy. A maximum of 5% of frozen tissue from each patient was used for our experiments. Prior to cryopreservation, a histological examination of the ovarian cortex was performed in order to secure a sufficient amount of primordial follicles.
|
Transplantation procedure
Surgery was performed under narcosis with ketamine (80 mg/kg bodyweight, Ketavet, Pharmacia & Upjohn, Erlangen, Germany) and xylazine (10 mg/kg bodyweight, Rompun, Bayer, Frankfurt, Germany), irrespective of the stage of the estrus cycle. During surgery, mice were kept on a warming plate, the incision site was disinfected with pure alcohol and covered with a sterile towel. Both mice ovaries were removed by a small body wall incision which was sutured with absorbable thread. One frozen/thawed human ovarian tissue piece was placed in an i.m. pocket of the neck muscle.
Study design
All mice were ovarectomized and assigned to two different experimental groups:
Study group A
The effect of triptorelin on the follicular development in gonadotropin-stimulated animals.
Study group B
The effect of triptorelin on the follicular development in gonadotropin untreated animals.
In study group A, 23 SCID animals were treated with HMG alone (group A1, n = 17) or with human menopausal gonadotropin (HMG) and triptorelin (group A2, n = 6), and in study group B, 18 SCID mice were treated either with saline (group B1, n = 10) or with only triptorelin (group B2, n = 8).
Gonadotropin stimulation
Mice received daily i.p. injections of HMG (Menogon, Ferring, Kiel; 1 IU FSH/1 IU LH per animal/day) or saline, starting from day 14 after transplantation for 15 weeks. This dose was adjusted from an earlier study by Oktay et al.(1998).
Estrus cycle stage determination
Vaginal smears were taken once a week from all mice starting at day 10 after transplantation using sterile pipettes, in order to examine if follicular tissue survived the transplantation and could produce enough estrogens to cornify the vaginal epithelium. Vaginal cells were left to dry after being smeared on a microscopic slide and then stained with methylene blue (Gunasena et al. 1997).
Pituitary downregulation with triptorelin treatment
Two weeks before the mice of groups A2 and B2 were ovarectomized, an i.m. injection of 8 mg GnRH agonist depot triptorelin in the form of microcapsules was administered. The injection was repeated every 4 weeks to ensure an adequate mice-pituitary negative feedback.
LIVE/DEAD assay
One ovarian tissue piece from each patient was examined for estimation of vitality. In order to estimate the number of follicles that survived the freezing/thawing procedure in vitro we used a fluorescence staining. The LIVE/DEAD viability/cytotoxicity assay kit (L-3224, Molecular Probes, Leiden, The Netherlands) provides a two-color fluorescence cell viability assay that is based on the simultaneous determination of live and dead cells. We used the kit with a Zeiss fluorescence microscope (IM 35, Zeiss, Oberkochen, Germany) in order to examine the viability of the frozenthawed tissue.
Live cells are distinguished by the presence of ubiquitous intracellular esterase activity, determined by the enzymatic conversion of the virtually non-fluorescent cell-permeating calcein AM to the intensely fluorescent calcein. The polyanionic dye calcein is well retained within live cells, producing an intense uniform green fluorescence in live cells (ex/em ~495/~515 nm). Ethidium homodimer-1 (EthD-1) enters cells with damaged membranes and undergoes a 40-fold enhancement of fluorescence upon binding to nucleic acids, thereby producing a bright red fluorescence in dead cells (ex/em ~495635 nm).
To perform the viability assay we used the following protocol: (a) the thawed tissue is dissected to as small as possible pieces with a scalpel; (b) 3 mg collagenase (Collagenase Type IV, Sigma-Aldrich) diluted in 3 ml Dulbeccos PBS (D-PBS) are added to the tissue; (c) the samples are left to incubate for approximately 2 h at 37 °C, while the homogenate is stirred periodically every 20 min; (d) the LIVE/DEAD reagent stock solutions are removed from the freezer and allowed to warm to room temperature; (e) the reagents are combined by adding 20 µl of the 2 mM EthD-1 stock solution and 5 µl supplied 4 mM calcein AM stock solution to 10 ml sterile, tissue culture-grade D-PBS; (f) the resulting approximately 2 µM calcein AM and 4 µM EthD-1 working solutions are added directly to the samples and left to incubate for 30 min in a dark place at room temperature; and (g) the labeled cells are viewed under the fluorescence microscope. Follicles were classified into four categories depending on the percentage of dead granulosa cells (Table 2
). Only when both the oocyte and all the granulosa cells were dead, was a follicle considered as dead.
|
|
The diameter of the nucleolus of primordial follicles was estimated to be
2 µm (Jones & Krohn 1961). Using a section thickness of 3 µm reduces the risk of over-counting, without totally eliminating it. Follicles were classified as follows: primordial follicles with one layer of flattened granulosa cells surrounding the oocyte; primary follicles with one layer of cuboid granulosa cells; preantral follicles with two or more layers of granulosa cells, but no antrum; and antral follicles with an antral cavity (Myers et al. 2004, Kerr et al. 2006).
Hormone determination and uterus weight
After the animals were killed, serum was collected for estradiol measurement by cardiac puncture. Total serum estradiol was measured by RIA without extraction by a commercial high-sensitive assay for rat and mouse serum (Diagnostic Systems Laboratories, Sinsheim, Germany). The uterine horns were removed, trimmed, and weighed after removing the surface moisture.
Statistical evaluation
Statistical Product and Service Solution (SPSS) was used for data evaluation. Nominal data were expressed as mean ± S.D. and compared using t-test. A P value of 0.05 was considered statistically significant. Significance of correlation was calculated according to Pearson.
| Results |
|---|
|
|
|---|
|
The results of the fluorescence staining are also given in Table 2
. Dead follicles were very rare.
Analysis of vaginal smears
In all mice except group B2, cornified epithelial cells were present. No regular cyclicity could be detected.
Uterine weights
The mean uterine weights of all study groups are shown in Table 3
. We found statistical differences between groups A1 and A2 and between B1 and B2. Our results show that the uterine weight is reduced by the administration of triptorelin in stimulated (P = 0.03) and non-stimulated animals (P<0.001).
Follicular survival and development
The results of the follicular count per patient are shown in Table 1
. Table 3
shows the results of the follicular count in the various study groups. Triptorelin caused a significant reduction of follicles in all developmental stages in the non-gonadotropin-stimulated animals (group B2; P<0.001). In gonadotropin-stimulated animals GnRH agonist treatment has no significant effect on primordial, primary, and preantral follicle count, whereas the antral follicles were significantly fewer (groups A1 and A2; P = 0.03).
Estradiol
Estradiol was measured in a highly sensitive estradiol RIA for mice. Nevertheless, the lower detection limit was 5 pg/ml. In all 41 animals, enough blood serum was collected for estradiol determination. In only six animals, estradiol concentrations of >5 pg/ml were found. In all of these animals, antral follicles were detected (only one animal had a triptorelin treatment, all animals received gonadotropin stimulation).
| Discussion |
|---|
|
|
|---|
The cryopreservation of ovarian tissue before the loss of reproductive function is today a realistic option for women facing cytotoxic cancer therapy (Falcone et al. 2004, Falcone & Bedaiwy 2005). Nevertheless, this technique is still in an experimental stadium and improvements in both the cryopreservation and retransplantation methods are necessary before it becomes routine. In order to validate the maintenance of the developmental potential of primordial follicles in the stored tissue, many groups have used the xenotransplantation in SCID mice (Weissman et al. 1999, Gook et al. 2003, Maltaris et al. 2006).
The aim of the study was to examine prospectively the effect of a GnRH agonist (triptorelin) on the number of follicles in different developmental stages of cryopreserved human ovarian grafts transplanted to gonadotropin-stimulated or not stimulated SCID mice and to test the hypothesis that GnRH agonist treatment may be able to prevent primordial follicular depletion.
The pre-freezing histological follicular count showed normal age-related follicular distribution in the ovary and is in accordance with findings of other studies (Siebzehnrubl et al. 2000, Schmidt et al. 2003). After thawing, we performed a LIVE/DEAD assay, xenotransplanted the tissue in SCID mice and tested the viability of the transplanted ovarian tissue by vaginal cytology, uterus weight, follicle count, and estradiol determination.
In only six animals, estradiol concentrations of >5 pg/ml were found. In all of these animals, antral follicles were present. It is known that the rodent reproductive system lacks a specific estradiol-binding globulin equivalent to the human sex hormone-binding protein (Janne et al.1999). Therefore, minute levels of estradiol are adequate for the normal reproductive function.
The cornifying of the epithelial cells of the vaginal mucosa, which is predominant in the estrus phase, demonstrated that the animals produced ovarian steroid hormones. The only group that showed no cornifying of the vaginal epithelial cells was the group with triptorelin treatment and no stimulation. This can be explained by the mouse pituitary downregulation in the absence of exogenous stimulation, which leads to a total estrogen production failure. Triptorelin reduced significantly the uterus weight in stimulated and not stimulated animals, which can be explained by a reduced estradiol release due to the pituitary downregulation. In the group that received no triptorelin or gonadotropin stimulation normal uterine weights were found, which also correlates with the work of Gook et al.(2001), who reported adequate circulating concentrations of FSH for follicle maturation in oophorectomized mice without exogenous FSH stimulation.
The results of the staining with the LIVE/DEAD florescent assay confirm that a high percentage of oocytes as well as granulosa cells survive the cryopreservation and thawing procedure. Our results are in accordance with other publications (Siebzehnrubl et al. 2000, Martinez-Madrid et al. 2004). It is known from other studies that the main reason for the follicular loss after cryopreservation and xenografting is the ischemic effect after transplantation rather than the cryopreservation (Liu et al. 2002, Maltaris et al. 2005).
The following factors influence the follicular distribution in transplantation studies: the inhomogeneous distribution of follicles in the ovarian cortex (intrapatient variation) (Schmidt et al. 2003), the age-related decline of follicles, the interpatient variation, and the size of the grafts (Broecke Van den et al. 2001).
This study demonstrates that a prolonged exogenous stimulation promotes the primordial follicle maturation but causes a loss of primordial follicles in xenotransplantated frozen/thawed human ovarian tissue grafts, which is in accordance to the known literature (Oktay et al. 1998, Gook et al. 2001, Dittrich et al. 2001, Maltaris et al. 2007). This depletion of the ovarian follicular reserve could be a result of a toxic effect of FSH or LH (Richardson & Nelson 1990, Flaws et al. 1997).
In our experiments, triptorelin, a GnRH agonist, which suppresses the FSH and LH release, was not able to preserve the primordial follicle fraction. It caused a significant reduction of follicles in all developmental stages in the non-gonadotropin-stimulated animals (B1 vs B2; P<0.001). In gonadotropin-stimulated animals, GnRH agonist treatment had no significant effect on primordial, primary, and preantral follicle count, whereas the antral follicles were significantly fewer (A1 vs A2; P = 0.03).
A possible explanation for this effect of triptorelin especially in the non-stimulated animals (B1 vs B2), could be the absence of gonadotropins in the neovascularization period directly after grafting. Dissen et al.(1994) have proven that gonadotropins play an important role in this critical period.
In the stimulated group (A1 vs A2), stimulation began 2 weeks after the ovarian transplantation, so that also in these animals a part of the follicular reserve was lost, although not statistically significant. The significant loss of the antral follicles in the downregulated and stimulated animals (A1 vs A2) can be explained by the not sufficiently compensating stimulation by exogenous gonadotropins (1 IU HMG/day per mouse) in our experiments.
We conclude that the GnRH agonist treatment with triptorelin is not able to prevent the primordial follicle depletion after the xenografting of ovarian tissue in SCID mice with or without gonadotropin stimulation, but can also cause an additional loss of follicles if administered during the critical neovascularization period after the transplantation.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Aubard Y, Poirot C, Piver P, Galinat S & Teissier MP 2001 Are there indications for ovarian tissue cryopreservation? Fertility and Sterility 76 414415.[CrossRef][Web of Science][Medline]
Blatt J 1999 Pregnancy outcome in long-term survivors of childhood cancer. Medical and Pediatric Oncology 33 2933.[CrossRef][Web of Science][Medline]
Broecke Van den R, Liu J, Handyside A, Van der Elst JC, Krausz T, Dhont M, Winston RM & Hovatta O 2001 Follicular growth in fresh and cryopreserved human ovarian cortical grafts transplanted to immunodeficient mice. European Journal of Obstetrics & Gynecology and Reproductive Biology 97 193201.[CrossRef][Web of Science][Medline]
Candy CJ, Wood MJ & Whittingham DG 1997 Effect of cryoprotectants on the survival of follicles in frozen mouse ovaries. Journal of Reproduction and Fertility 110 1119.
Demeestere I, Simon P, Englert Y & Delbaere A 2003 Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility. Reproductive BioMedicine Online 7 572579.[Medline]
Dissen GA, Lara HE, Fahrenbach WH, Costa ME & Ojeda SR 1994 Immature rat ovaries become revascularized rapidly after auto-transplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology 134 11461154.
Dittrich R, Recabarren S, Mitze M & Jaeger W 2001 Role of gonadotropins in malignant progression of sex cord stromal tumors produced by sequential auto- and isogenic transplantation of ovarian tissue in ovariectomized rats. Journal of Cancer Research and Clinical Oncology 127 495501.[CrossRef][Web of Science][Medline]
Donnez J & Bassil S 1998 Indications for cryopreservation of ovarian tissue. Human Reproduction Update 4 248259.
Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B & van Langendonckt A 2004 Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364 14051410.[CrossRef][Web of Science][Medline]
Falcone T & Bedaiwy MA 2005 Fertility preservation and pregnancy outcome after malignancy. Current Opinion in Obstetrics and Gynecology 17 2126.
Falcone T, Attaran M, Bedaiwy MA & Goldberg JM 2004 Ovarian function preservation in the cancer patient. Fertility and Sterility 81 243257.[CrossRef][Web of Science][Medline]
Flaws JA, Abbud R, Mann RJ, Nilson JH & Hirshfield AN 1997 Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary. Biology of Reproduction 57 12331237.[Abstract]
Gook DA, Edgar DH & Stern C 1999 Effect of cooling rate and dehydration regimen on the histological appearance of human ovarian cortex following cryopreservation in 1, 2-propanediol. Human Reproduction 14 20612068.
Gook DA, McCully BA, Edgar DH & McBain JC 2001 Development of antral follicles in human cryopreserved ovarian tissue following xenografting. Human Reproduction 16 417422.
Gook DA, Edgar DH, Borg J, Archer J, Lutjen PJ & McBain JC 2003 Oocyte maturation, follicle rupture and luteinization in human cryopreserved ovarian tissue following xenografting. Human Reproduction 18 17721781.
Gunasena KT, Villines PM, Critser ES & Critser JK 1997 Live births after autologous transplant of cryopreserved mouse ovaries. Human Reproduction 12 101106.
Janne M, Hogeveen KN, Deol HK & Hammond GL 1999 Expression and regulation of human sex hormone-binding globulin transgenes in mice during development. Endocrinology 140 41664174.
Jones EC & Krohn PL 1961 The relationships between age, numbers of oocytes and fertility in virgin and multiparous mice. Journal of Endocrinology 21 469495.[Web of Science][Medline]
Kerr JB, Duckett R, Myers M, Britt KL, Mladenovska T & Findlay JK 2006 Quantification of healthy follicles in the neonatal and adult mouse ovary: evidence for maintenance of primordial follicle supply. Reproduction 132 95109.
Liu J, Van der Elst J, Van den Broecke R & Dhont M 2002 Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Human Reproduction 17 605611.
Liu HC, He Z & Rosenwaks Z 2003 Mouse ovarian tissue cryopreservation has only a minor effect on in vitro follicular maturation and gene expression. Journal of Assisted Reproduction and Genetics 20 421431.[CrossRef][Web of Science][Medline]
Maltaris T, Dimmler A, Muller A, Binder H, Hoffmann I, Kohl J, Siebzehnrubl E, Beckmann MW & Dittrich R 2005 The use of an open-freezing system with self-seeding for cryopreservation of mouse ovarian tissue. Reproduction of Domestic Animals 40 250254.[CrossRef]
Maltaris T, Kaya H, Hoffmann I, Mueller A, Beckmann MW & Dittrich R 2006 Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue. In Vivo 20 1116.[Web of Science][Medline]
Maltaris T, Beckmann MW, Mueller A, Hoffmann I, Kohl J & Dittrich R 2007 Significant loss of primordial follicles after prolonged gonadotropin stimulation in xenografts of cryopreserved human ovarian tissue in severe combined immunodeficient mice. Fertility and Sterility 87 195197.[CrossRef][Web of Science][Medline]
Martinez-Madrid B, Dolmans MM, Van Langendonckt A, Defrere S & Donnez J 2004 Freeze-thawing intact human ovary with its vascular pedicle with a passive cooling device. Fertility and Sterility 82 13901394.[CrossRef][Web of Science][Medline]
Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E & Dor J 2005 Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. New England Journal of Medicine 353 318321.
Myers M, Britt KL, Wreford NG, Ebling FJ & Kerr JB 2004 Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127 569580.
Newton H, Aubard Y, Rutherford A, Sharma V & Gosden R 1996 Low temperature storage and grafting of human ovarian tissue. Human Reproduction 11 14871491.
Oktay K, Newton H, Mullan J & Gosden RG 1998 Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Human Reproduction 13 11331138.
Recabarren SE, Dittrich R, Jager W & Wildt L 1991 Pasma luteinizing hormone bioactivity and immunoactivity in ovariectomized rats treated with a long-acting agonist of luteinizing hormone releasing hormone. Human Reproduction 6 928930.
Richardson SJ & Nelson JF 1990 Follicular depletion during the menopausal transition. Annals of the New York Academy of Science 592 1320.[Web of Science][Medline]
Schally AV, Coy DH & Arimura A 1980 LH-RH agonists and antagonists. International Journal of Gynecology and Obstetrics 18 318324.
Schmidt KL, Byskov AG, Nyboe-Andersen A, Muller J & Yding-Andersen C 2003 Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Human Reproduction 18 11581164.
Siebzehnrubl E, Kohl J, Dittrich R & Wildt L 2000 Freezing of human ovarian tissuenot the oocytes but the granulosa is the problem. Molecular and Cellular Endocrinology 169 109111.[CrossRef][Web of Science][Medline]
Siebzehnrubl E 2003 Cryopreservation of ovarian tissue to preserve female fertility state of the art. Andrologia 35 180181.[CrossRef][Medline]
Weissman A, Gotlieb L, Colgan T, Jurisicova A, Greenblatt EM & Casper RF 1999 Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD-SCID mouse. Biology of Reproduction 60 14621467.
This article has been cited by other articles:
![]() |
I. Demeestere, P. Simon, S. Emiliani, A. Delbaere, and Y. Englert Orthotopic and heterotopic ovarian tissue transplantation Hum. Reprod. Update, May 27, 2009; (2009) dmp021v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. MALTARIS, M. W. BECKMANN, and R. DITTRICH Fertility Preservation for Young Female Cancer Patients In Vivo, January 1, 2009; 23(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Amorim, A. Van Langendonckt, A. David, M.-M. Dolmans, and J. Donnez Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix Hum. Reprod., January 1, 2009; 24(1): 92 - 99. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |